GL1X · GenesisL1 explorer

Research workbench

Ricin bound to vhh antibody V5E1

Analyse Ricin bound to vhh antibody V5E1 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7KBI
Type
protein
Length
641 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ricin chain a; Ricin chain B; Vhh antibody V5E1
EC
3.2.2.22
UniProt
P02879
Ligands
NAG, BMA, CL
Pockets
7 · best druggability 0.81

Structure

x-ray diffraction · 3 distinct chains · 21% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARicin chain a (EC 3.2.2.22)protein25939% helix, 23% strandP02879
BRicin chain B (EC 3.2.2.22)protein2568% helix, 36% strandP02879
CVhh antibody V5E1protein1267% helix, 44% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 6 copies · chains A, B
  • BMA · beta-D-mannopyranose · sugar
  • CL · Chloride ion · ion · 4 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12620.810.9350empty
23870.610.7736empty
32000.590.8135empty
42620.570.7835empty
5980.500.8220empty

Interfaces

3 interfaces between chains.

  • A–B · 1671 Ų buried · 19 hydrogen bonds · protein-protein
  • A–C · 590 Ų buried · 12 hydrogen bonds · protein-protein
  • B–C · 235 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 7 disulfide, 3 glycan (disulfide, N-glycosylation).

Compared structures

  • 7KBI · Ricin bound to VHH antibody V5E1 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.